Navigation Links
UPDATE: Free CME-certified Webcast: Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key
Date:10/10/2007

SEATTLE, Oct. 9 /PRNewswire/ -- Emergency departments (ED) hold a critical key in improving acute coronary syndromes (ACS) outcomes. Does your community- based ED have all the tools that you need to improve ACS care? This CME- certified symposium, "Opening the Door to Better Myocardial Infarction Outcomes: Emergency Departments Hold the Key," will be led by top ED - cardiology experts, Deborah Diercks, MD; James Hoekstra, MD; and Charles Pollack, Jr., MD. They will describe ways in which community-based EDs can apply new treatment guidelines and clinical trial evidence to their chest pain patients treated for ACS. As chest pain represents the second-largest patient population that EDs treat, this interactive, case-based session will provide a lively description of how ED health care providers can continue to advance treatment and outcomes for this prevalent population, through improved triage and diagnosis, shortened door to balloon/needle times, and optimal upstream adjuvant therapy.

The free CME-certified Webcast will be presented on October 10, from 5:30 AM to 8:00 AM. Broadcast live during the American College of Emergency Physicians Scientific Assembly, this innovative, case-based symposium will provide emergency physicians and other clinicians with detailed information on treating patients with acute myocardial infarction. This activity is sponsored by INNOVIA Education Institute and supported by and educational grant from sanofi-aventis, U.S.

TITLE: Opening the Door to Better Myocardial Infarction Outcomes:

Emergency Departments Hold the Key

FACULTY: Deborah B. Diercks, MD, University of California, Davis;

James W. Hoekstra, MD, Wake Forest University Baptist

Medical Center; Charles V. Pollack, Jr., MD, Pennsylvania

Hospital

WHEN: Wednesday, October 10, 2007; 6:00 AM-8:00 AM PST

WHERE:

SOURCE INNOVIA Education Institute, LLC
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Merge files financial reports by market opening
2. HotMasterAn innovative Hot Start/Cold Stop technology for better PCR* results
3. A Better Way to Isolate RNA AND Protein From the Same Sample
4. Better RNA Amplification
5. Designing a Better siRNA
6. IMPROVE SILENCING SUCCESS: siRNAs THAT WORK BETTER!
7. RNA Amplification Just Got Better: MessageAmp II
8. Wisconsin fares slightly better in venture capital chase
9. Economic survey reveals better 2006 results
10. Technology changing for better, Coburn says
11. Internet Scout Project develops better tools for online research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2008)...Newswire/ -- BioTrends Research Group, Inc.,releas...M) publication, a,syndicated report offering compr...ia and bone and mineral metabolism in Chronic Kidn... information from 182 US,Nephrologists -- data wer...ne 2008., In the renal anemia market, while the u...
(Date:7/25/2008)...X, CALGARY, July 25 / Resv...X:RVX) is pleased to announce effective,immediatel...irectors. On,the subject of her appointment Jan Gr...xciting opportunity for me. The Company has done a...linical trials. I expect the next,foreseeable futu...
(Date:7/25/2008)...swire-FirstCall/ -- Caraco Pharmaceutical,Laborato...first quarter of,Fiscal 2009, ended June 30, 2008,...or the corresponding period of Fiscal 2008. This r...er of Fiscal 2008. Pre-tax income grew,to $14.6 mi...ared to a,pre-tax income of $9.6 million during th...
(Date:7/25/2008)...25 /- REvolution Computing will,lead ...R product at the,upcoming BioC 2008 conference in ... REvolution Computing Director of Community, Dr. D... Training Manager, and Martin Morgan of,the Fred H...ting,s BioC lab,will introduce participants to the...
Breaking Biology Technology:BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 2BioTrends Releases Quarterly TreatmentTrends(TM): Nephrology Report Highlighting Market Trends for Renal Anemia, Hyperphosphatemia, and Secondary Hyperparathyroidism 3Jan Gray Joins Resverlogix Board of Directors 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 2Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 3Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 4Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 5Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 6Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the First Quarter of Fiscal Year 2009 7REvolution Computing Offers Hands-On Tutorial of NWS Parallel Computing Environment at BioC 2008 2
...early peek at what would turn out to be a major ne...the ceiling. , ,As a physics post-doc at the Unive...olds sawed a hole in the ceiling of an office of t...ting a specially built spectrometer through the ro...ear view of a faint glowing gas that permeates the...
...., a provider of information management systems, ...portfolio management and investment accounting sol...rder processing through trade execution, accountin... reporting. , ,Brookfield-based Fiserv designed e...sing dates and the software is capable of managing...
...ice-fishing net, a polymer sorting machine and a B...of a field of 22 inventions University of Wisconsi...Days , Feb. 12 and 13. , ,The projects competed fo...ototype Prize, both sponsored by UW-Madison alumni...e marketplace. , ,We place quite a bit of weight o...
...2004 Conference kicked off today with a high leve... who traveled to Scottsdale for this event which i... new consumer and enterprise technology products. ... international media, venture capitalists, and vet...reneurs introduce new products, and technologies i...
Other Biology Technology:Journey Leads Astronomer to New Galactic Structure 2Journey Leads Astronomer to New Galactic Structure 3UW-Madison Undergrads Shine at Innovation Days 2Entrepreneurs Preview Liberating Technologies 2Entrepreneurs Preview Liberating Technologies 3
(Date:7/24/2008)...sity College of Medicine, Hershey, Pennsylvania ha...inically important immune response modifier with p...nt on the Opioid Growth Factor (OGF)-OGF receptor ...ted in the August 08 issue of Experimental Biolog...ly used drug that may lead to development of new a...
(Date:7/24/2008)... might tell potential suitors, "I like the way you...r look. But worms send their valentines via signal...earchers are now cracking, according to a study pu... . , Scientists from the University of Florida,...echnology and the U.S. Department of Agriculture h...
(Date:7/24/2008)... storage in western U.S. forests , Active fire ...caused a widespread increase in fire-intolerant tr...ng on trees within western U.S. forests. These fac...to account for much of North America,s carbon sink...s, Fellows and Goulden compare California forest i...
(Date:7/23/2008)...ternationally renowned scientists from 12 countrie...alia and India to address ancient microscopic fos...ing together the world,s best scientists in the fi...liam Schopf, founder and director of the UCLA Inst...for the Study of Evolution and the Origin of Life ...
Breaking Biology News(10 mins):Imiquimod, an immune response modifier, is dependent on the OGF-OGFr signaling pathway 2Mate or hibernate? That's the question worm pheromones answer 2Mate or hibernate? That's the question worm pheromones answer 3AGU journal highlights -- July 23, 2008 2AGU journal highlights -- July 23, 2008 3AGU journal highlights -- July 23, 2008 4AGU journal highlights -- July 23, 2008 5AGU journal highlights -- July 23, 2008 6AGU journal highlights -- July 23, 2008 7AGU journal highlights -- July 23, 2008 8UCLA 'world summit' to explore ancient life on Earth, and beyond 2DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 1DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 2Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 1Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 2French paradox redux 3F US vs French on being full 12046 1Alessi Skin Care Aligns With Celebrity Socialite Fabian Basabe to Raise Awareness for Their Face Forward Campaign 12042 1Alessi Skin Care Aligns With Celebrity Socialite Fabian Basabe to Raise Awareness for Their Face Forward Campaign 12042 2
...ome of patients with type 2 diabetes (DT2) has bee...e of new DNA chip technologies allowing 400,000 DN...s conferring a predisposition to DT2 have been ide...reatic insulin-secreting cells (ZnT8), which is a ...French population was carried out as a French-Brit...
... findings, which are being published the week of F... of the National Academy of Sciences, offer signif...ell as those that lead to abnormal amyloid fibril ...very of novel therapeutic targets for neurodegener... amyloids can play beneficial roles. The subject o...
...ype of protein discovered by Queen’s University re...or antibiotic-resistant bacteria, such as those th... the structure and activity of the protein ?called...rom the departments of Biochemistry and Microbiolo...r new drug development. , “Our group is the fi...
...hers from the Virginia Commonwealth University Mas...arch at the American Association of Cancer Researc...ew combination treatment for chronic lymphocytic l...ant, M.D., Massey,s associate director of translat...d romidepsin (Gloucester Pharmaceuticals) and bort...
Other Biology News:Elucidation of the genome for diabetics with DNA chips 2Elucidation of the genome for diabetics with DNA chips 3Scripps research study reveals structural dynamics of single prion molecules 2Scripps research study reveals structural dynamics of single prion molecules 3Protein discovery targets antibiotic-resistant bacteria 2
Proteinase K Buffer 3.9 ml
Rabbit polyclonal to hCG ( Abpromise for all tested applications). entrezGeneID: 1081 SwissProtID: P01215
Anti-Indolamine (Indoleamine) 2,3-dioxygenase Immunogen: Recombinant human IDO. Available Date: 38454
Glutathione Agarose Beads 10 ml
Biology Products: